Utah Medical Products (UTMD) Equity Average (2016 - 2025)
Utah Medical Products (UTMD) has 15 years of Equity Average data on record, last reported at $117.9 million in Q3 2025.
- For Q3 2025, Equity Average fell 5.02% year-over-year to $117.9 million; the TTM value through Sep 2025 reached $117.9 million, down 5.02%, while the annual FY2024 figure was $122.9 million, 1.31% up from the prior year.
- Equity Average reached $117.9 million in Q3 2025 per UTMD's latest filing, up from $117.3 million in the prior quarter.
- Across five years, Equity Average topped out at $128.0 million in Q1 2024 and bottomed at $103.9 million in Q1 2021.
- Average Equity Average over 5 years is $115.7 million, with a median of $117.2 million recorded in 2025.
- Peak YoY movement for Equity Average: rose 13.82% in 2023, then decreased 8.43% in 2025.
- A 5-year view of Equity Average shows it stood at $108.6 million in 2021, then grew by 2.45% to $111.2 million in 2022, then grew by 13.3% to $126.0 million in 2023, then dropped by 4.12% to $120.8 million in 2024, then dropped by 2.42% to $117.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Equity Average were $117.9 million in Q3 2025, $117.3 million in Q2 2025, and $117.2 million in Q1 2025.